Outlook Therapeutics, Inc. ( OTLK) - Key Metrics
OTLK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | -$0.02 | -$0.38 | -$248,137.38 | -$248,137.38 |
| 2025Q4 | $0 | -$0.38 | -$0.36 | -$0.36 |
| 2025Q3 | $0.04 | -$0.55 | -$0.32 | -$0.32 |
| 2025Q2 | ? | -$1.50 | -$0.54 | -$0.54 |
OTLK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | -1.03 |
| 2025Q4 | ? | -0.69 |
| 2025Q3 | ? | -0.73 |
| 2025Q2 | ? | -0.20 |
OTLK Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -46479784.33% | ? |
| 2026Q1 | -15704897.51% | ? |
| 2025Q4 | -33.56% | ? |
| 2025Q3 | -20.13% | ? |
| 2025Q2 | -44.03% | ? |
OTLK
Price: $1.58
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.13 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 308347
Market Capitalization: 30.6 million